Through these data bases we collected twelve
years-data for these firms. Our review yielded 11 farms valuing biological assets at fair
value and 101 at historical cost and 5 were discarded because they did not provide
information about their valuation method, or it was not clear the applied method, and/or
there was no available financial data for them.